ReviewFrontiers in cellular neuroscience2015

Combination Low-Dose Tissue-Type Plasminogen Activator Plus Annexin A2 for Improving Thrombolytic Stroke Therapy.

Yinghua Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.